RPL7P32: A Promising Drug Target / Biomarker (G100130892)

Target Name: RPL7P32

NCBI ID: G100130892

Other Name(s): Ribosomal protein L7 pseudogene 32 | RPL7_15_834 | RPL7P | ribosomal protein L7 pseudogene 32

RPL7P32: A Promising Drug Target / Biomarker

RPL7P32 is a gene that encodes a protein known as protamine alpha chain subunit 2 (PACS2). The PACS2 protein is a key component of the nucleosome, a complex structure that organizes DNA in the nucleus of a cell. PACS2 functions as a scaffold protein, helping to keep the DNA in the proper position. Mutations in the RPL7P32 gene have been linked to various diseases, including cancer and neurodegenerative disorders. As a result, RPL7P32 has become an attractive drug target for researchers to explore.

The Importance of the Nucleosome

The nucleosome is a critical structure that plays a crucial role in the organization of DNA in the nucleus of a cell. It is a small protein complex that consists of several subunits, including P120, P160, P210, and P220. These subunits form a repeating unit called a nucleosome and are held together by ionic bonds. The nucleosome is the

Protein Name: Ribosomal Protein L7 Pseudogene 32

More Common Targets